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Abstract 36 
Immune-related events in the periphery can remotely affect brain function, contributing to 37 
neurodegenerative processes and cognitive decline. In mice, peripheral surgery induces a 38 
systemic inflammatory response associated with changes in hippocampal synaptic plasticity 39 
and transient cognitive decline, however the underlying mechanisms remain unknown. Here 40 
we investigated the effect of peripheral surgery on neuronal-glial function within 41 
hippocampal neuronal circuits of relevance to cognitive processing in male mice at 6, 24, and 42 
72h post-surgery. At 6h we detect the pro-inflammatory cytokine IL-6 in the hippocampus, 43 
followed up by alterations in the mRNA and protein expression of astrocytic and neuronal 44 
proteins necessary for optimal energy supply to the brain and for the reuptake and recycling 45 
of glutamate in the synapse. Similarly, at 24h post-surgery the mRNA expression of 46 
structural proteins (GFAP and AQP4) was compromised. At this time point, functional 47 
analysis in astrocytes revealed a decrease in resting calcium signaling. Examination of 48 
neuronal activity by whole-cell patch clamp shows elevated levels of glutamatergic 49 
transmission and changes in AMPA receptor subunit composition at 72h post-surgery. 50 
Finally, lactate, an essential energy substrate produced by astrocytes and critical for memory 51 
formation, decreases at 6- and 72h after surgery. Based on temporal parallels with our 52 
previous studies, we propose that the previously reported cognitive decline observed at 72h 53 
post-surgery in mice might be the consequence of temporal hippocampal metabolic, 54 
structural and functional changes in astrocytes that lead to a disruption of the neuro-glial 55 
metabolic coupling and consequently to a neuronal dysfunction.  56 
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Significance Statement 57 
A growing body of evidence suggests that surgical trauma launches a systemic inflammatory 58 
response that reaches the brain and associates with immune activation and cognitive decline. 59 
Understanding the mechanisms by which immune-related events in the periphery can 60 
influence brain processes is essential for the development of therapies to prevent or treat 61 
postoperative cognitive dysfunction and other forms of cognitive decline related to immune-62 
to-brain communication, such as Alzheimer’s and Parkinson’s diseases. Here we describe the 63 
temporal orchestration of a series of metabolic, structural and functional changes after 64 
aseptic trauma in mice related to astrocytes and later in neurons that emphasize the role of 65 
astrocytes as key intermediaries between peripheral immune events, neuronal processing, and 66 
potentially cognition. 67 
  68 
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Introduction 69 
Despite the classical view of the central nervous system (CNS) as an immune privilege organ, 70 
growing evidence points to an active crosstalk between the peripheral immune system and 71 
the CNS, which suggests that immune-related events in the periphery can remotely affect 72 
brain function, contributing to neurodegenerative processes and cognitive decline (Perry et 73 
al., 2003). 74 
Activation of the peripheral innate immune system after trauma (e.g. surgery) leads to the 75 
increase of pro-inflammatory cytokines in both the systemic circulation and the CNS. 76 
Importantly, this increase in cytokines has been associated with prolonged impairment in 77 
learning and memory (Buvanendran et al., 2006; Beloosesky et al., 2007; Kline et al., 2016). 78 
Recently, the first PET study of the human brain immune activity after surgery using PBR28, 79 
a novel translocator protein (TSPO) ligand, revealed a profound postoperative dysregulation 80 
of brain glial activity even at 3 to 4 months after surgery associated with poor cognitive 81 
outcome (Forsberg et al., 2017). In surgical rodent models, such periphery-to-brain 82 
inflammatory pathway seems critically dependent on NF-kB and pro-inflammatory cytokine 83 
signaling (e.g., tumor necrosis factor-a [TNF-a]), associated with a transient disruption of 84 
blood–brain barrier (BBB) integrity, migration of peripheral macrophages into the 85 
hippocampus, and subsequent cognitive impairment (Terrando et al., 2010; Terrando et al., 86 
2011; Degos et al., 2013; Yang et al., 2017). However, the consequence of this periphery-to-87 
brain signaling on hippocampal function remains largely unknown. We recently 88 
demonstrated that surgery-induced cognitive decline in mice was associated with 89 
hippocampal astrocytic morphology alteration and synaptic plasticity impairment. Notably, 90 
the astrocytic change preceded the neuronal impairment (Terrando et al., 2013), suggesting 91 
that primary changes in astrocyte function have the potential to modulate large-scale 92 
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neuronal functional systems. With its typical location having one part of the cell attached to 93 
the vascular wall and the other part in close proximity to the synapse, astrocytes emerge as 94 
pivotal mediators between the periphery and neuronal functions. However, the effects of 95 
systemic immune activation and inflammation on astrocyte functions are not well defined.  96 
In the last decade, a large body of evidence suggests that an array of systemic challenges 97 
(including surgery) can promote a systemic inflammatory response that may contribute to 98 
the exacerbation of acute symptoms of chronic neurodegenerative disease, such as 99 
Alzheimer’s disease (AD) and Parkinson’s disease (PD), thus accelerating disease progression 100 
(Perry et al., 2007; Collins et al., 2012). Indeed, a series of disease-generating mechanisms 101 
observed after peripheral trauma have also been described on these and other brain 102 
disorders associated with cognitive dysfunction, such as BBB disruption and infiltration of 103 
activated macrophages (Lebson et al., 2010; Birch et al., 2014; Perry and Holmes, 2014).  104 
To further understand the temporal pattern of immune activation and simultaneous changes 105 
in synaptic transmission within hippocampal neuronal circuits of relevance for cognitive 106 
processing, we investigated the effect of surgery on neuronal-glial function combining 107 
calcium (Ca2+) imaging in astrocytes and whole-cell patch clamp in CA1 pyramidal cells with 108 
structural and metabolic analysis in mice. Our findings uncover a role for astrocytes as 109 
mediators between systemic immune and inflammatory events and synaptic neuronal 110 
functions including a dysregulation of brain energy metabolism, which may be in turn related 111 
to the surgical phenotype, including cognitive impairment post-surgery. 112 
  113 
  7 
Material and Methods 114 
Animals 115 
All experiments were approved by the Local Ethics Committee for Animal Research at 116 
Karolinska Institutet (Stockholm, Sweden) and comply with the Society for Neuroscience 117 
policy on the use of animals in research. Male, 12-14 weeks old C57BL6 (Charles River, 118 
Germany) and CX3CR1GFP/+CCR2RFP/+ mice (generated as previously described (Saederup et 119 
al., 2010) and kindly donated by Akassoglou K, J. David Gladstone Institutes, San Francisco, 120 
California, USA) were used. Mice were housed 6/cage under temperature- and humidity-121 
controlled conditions with 12-h light-dark cycle and fed standard rodent chow and water ad 122 
libitum. All animals were weighted just before surgery (or saline injection in the case of the 123 
naïve animals) and before brain collection.  124 
Surgery 125 
The open stabilized tibia fracture model was performed as previously described (Terrando et 126 
al., 2013). Briefly, under isoflurane anesthesia (2.1% inspired concentration in 0.30 FiO2) and 127 
analgesia (buprenorphine, 0.1 mg/kg s.c.) a longitudinal incision was made on the left hind 128 
paw and the muscles disassociated. A 0.38-mm stainless steel pin was then inserted in the 129 
intramedullary canal and the osteotomy was performed. The wound was irrigated, sutured 130 
with 6-0 Prolene, and the mice were allowed to recover in a warm box before returning to 131 
the home cage. The procedure lasted 21 r 0.5 min. Temperature was monitored and 132 
maintained at 37°C with the aid of a warming pad and temperature controlled lights 133 
(Harvard Apparatus, Holliston, MA, USA). Animals sacrificed at 24-72h post-surgery 134 
received a daily dose of analgesia (buprenorphine, 0.1 mg/kg s.c.) during the length of the 135 
study. Control mice received an equal volume of saline (s.c.). 136 
Acute brain slices  137 
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Mice were terminated at 6-24-72 hours after tibia fracture completion by cervical dislocation. 138 
The brain was quickly harvested following decapitation and the whole hippocampus 139 
removed into ice-cold oxygenated (95% O2 and 5% CO2) artificial cerebrospinal fluid 140 
solution (aCSF) containing (in mM): 130 NaCl, 3.5 KCl, 1.25 NaH2PO4, 24 NaHCO3, 2 141 
CaCl2, 1.5 MgCl2, and 10 glucose, pH 7.4 (330 mOsmol). Horizontal hippocampal slices (400 142 
Pm) were prepared with a vibratome (VT1200S, Leica), and the slices were incubated for 20 143 
min in an interface chamber containing oxygenated aCSF warmed at 34°C and then left for 144 
approximately 40 min at room temperature.  145 
Ca2+ imaging  146 
Mouse brain slices were prepared as described previously. After recovering, slices containing 147 
the hippocampus were transferred to a customized loading chamber: a millicell culture insert 148 
for organotypical cultures (Millicell; Merk-Millipore, Germany) fitted in a 35mm petri-dish 149 
and placed into a 100 mm petri-dish with bubbling tubing glued around it and a lid with a 150 
gas entrance to allow continuous oxygenation (95% O2 and 5% CO2). Both, the 35 mm and 151 
100 mm petri-dishes were filled with regular aCSF (1150 Pl and 5 ml, approximately).  152 
Loading and mounting. To identify hippocampal astrocytes, slices were first loaded with 153 
Sulforhodamine 101 (S101) for 15 min, washed and loaded with the Ca2+ indicator dye 154 
Oregon Green 488 BAPTA-1 AM (OGB-1, 50 Pg) previously dissolved in a solution 155 
containing: 9 Pl 0.5% Cremophor EL (in DMSO) + 1Pl Pluronic F127 (in DMSO) + 10Pl 156 
regular aCSF (20 PM OGB-1; 0.002 PM Cremophor EL; 0.01% Pluronic F127; 0.5% 157 
DMSO). A 5Pl drop of the OGB-1 dye solution was placed on top of each individual slice 158 
and incubated for 45-60 min at 37 °C. After that period, the aCSF was replaced for fresh 159 
aCSF and the slices recovered for 30 min at room temperature. For Ca2+ imaging, slices were 160 
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mounted upside-down in bottom glass culture dishes (MatTek Corporation, USA) pre-161 
coated with PEI (1ml for 1h at room temperature and rinsed 3-5 times with distilled water 162 
and aCSF). To avoid possible detachment during imaging, the borders of the slices were 163 
carefully dried with the help of a filter paper and the slice gently covered with 1ml of aCSF. 164 
Once mounted, the slices were kept in the oxygenated chamber before being transferred 165 
individually to the recording chamber (Warner Instruments, USA).  166 
Imaging. Slices were continuously perfused with aCSF at room temperature and astrocytes 167 
were identified in the CA1 area with a 25X objective in an upright laser-scanning confocal 168 
microscopy (LSM 710 from Carl Zeiss, Germany). S101 was excited at 568 nm and collected 169 
through a 630 long-pass filter while OGB-1 was excited at 488 nm and collected through a 170 
522±16 nm band-pass filter.  171 
Spontaneous astrocytic Ca2+ transients were recorded from live hippocampal astrocytes 172 
loaded with both OGB-1 and S101 in time-series images of 300-600 frames collected at 1 s 173 
intervals. At the end of the experiments, ATP (100nM) was applied to monitor typical 174 
calcium responses of astrocytes. The slices that did not respond to ATP were excluded for 175 
the analysis.   176 
The acquired image stacks were registered using the turboreg plugin (Thevenaz et al., 1998) 177 
of Fiji (RRID:SCR_002285) (Schindelin et al., 2012). The cells were then identified as 178 
connected components of the binary images after semi-automated thresholding and size 179 
filtering of the SR101 immunofluorescence. The signal intensity of OGB-1AM in each cell 180 
was quantified and exported from Fiji (RRID:SCR_002285) to be further processed using a 181 
custom python script. The fluorescence signal was converted in dF/F0 where F0 was the 182 
mean fluorescence signal of the trace, and all the peaks in the trace were labeled. A response 183 
was defined as a peak with dF/F0 above 10  % of F0. 184 
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Electrophysiology  185 
For whole-cell voltage clamp recordings of CA1 pyramidal cells, after slice recovery, a single 186 
slice was transferred to a submersion recording chamber, where it was continuously perfused 187 
(1.8–2 ml/min) with regular aCSF warmed to 31–32°C. Patch electrodes (4–6 M:) were 188 
filled with a solution containing (in mM): 110 (for excitatory postsynaptic currents (EPSCs)) 189 
or 20 (for inhibitory PSCs (IPSCs)) K-gluconate, 10 (for EPSCs) or 100 (for IPSCs) KCl, 4 190 
Mg2-ATP, 10 phosphocreatine, 0.3 Na2-GTP and 10 HEPES, pH 7.3 with KOH (270–290 191 
mOsm). Cells were voltage clamped at -65mV, and either spontaneous EPSCs or IPSCs 192 
were recorded using a Multiclamp 700B amplifier (Molecular Devices, Sunnyvale, CA, USA). 193 
The data were acquired using pCLAMP 10 (Molecular Devices, Sunnyvale, CA, USA). 194 
Recordings with a membrane potential (Vm) more positive than -55mV and/or access 195 
resistances (Rs)>30 M: were excluded, and only cells with stable Rs and Vm (i.e., a change 196 
of <10%) were included in the analysis. All PSCs were analyzed using Mini Analysis software 197 
(Synaptosoft, Decatur, GA, USA). Detection criteria included EPSCs and IPSCs with an 198 
amplitude >7.5 pA and a 20–80% decay-rise time >0. Data represent the average of 3 min of 199 
recording. The numerical values are expressed as the mean± SEM and n indicates the 200 
number of neurons tested. 201 
Brain collection 202 
Animals were cardially perfused with cold PBS (20ml) and the hippocampus dissected and 203 
wet weighted in lock-safe tubes and stored at -80°C until further analysis.  204 
Preparation of brain tissue for cytokine analysis  205 
Hippocampal samples from cold PBS cardially perfused animals were homogenized in ice-206 
cold lysis buffer (100mg/ml) (in mM): 150 NaCl, 20 Tris pH 7.5, 1 EDTA; 1 EGTA; 1% 207 
triton X-100; protease inhibitor (Roche, Sigma-Aldrich); Phosphatase Inhibitor Cocktail 3 208 
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(Sigma-Aldrich) Phosphatase Inhibitor 2 (Sigma-Aldrich); 200ul NaF (from 0.5M stock), 209 
with glass beads for 3-5 minutes with speed 8 at 4°C using a Bullet-Blender (Next Advance, 210 
Averill Park, NY). Homogenates were then centrifuged 14 000 rpm for 10 min at 4°C. 211 
Cytokines were directly analyzed the same day following the multiplex cytokine assay 212 
protocol (see below). 213 
Multiplex cytokine assay 214 
Brain pro- and anti-inflammatory cytokine levels were determined with Mouse Pro-215 
inflammatory 10 Plex Ultrasensitive Plate (IFN-gamma, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-10, 216 
IL-12 p70, KC/GRO (CXCL1), and TNF-D) from Meso Scale Discovery (Rockville, USA) 217 
at 6-72h after tibia fracture completion according to manufacturer’s instructions. 218 
Western Blot (WB) 219 
Hippocampal samples were homogenized in 1% sodium dodecyl sulphate (SDS) buffer 220 
containing protease and phosphate inhibitors (Sigma-Aldrich). Protein concentration was 221 
determined using the BCA Protein Assay Kit (Thermo Scientific) and equal amounts of 222 
protein (20–30μg) were resolved by SDS-PAGE and transferred onto a PVDF membrane 223 
(Invitrogen). Detection was done by enhanced chemiluminescence with Amersham ECL 224 
western blotting detection reagents (GE Healthcare). Chemiluminescence was determined 225 
with a ChemiDoc MO analyzer (Bio-Rad). Band intensities were quantified by densitometry 226 
using ImageJ software (NIH, Bethesda, MD, USA). Ponceau S staining of the membrane 227 
was used as a loading control (Romero-Calvo et al., 2010). Primary antibodies were rabbit 228 
monoclonal anti-glutamate Receptor 1 (AMPA subtype) (1:1000, Abcam Cat# ab109450 229 
RRID:AB_10860361); rabbit polyclonal anti-glutamate Receptor 2 (1:1000, Abcam Cat# 230 
ab20673 RRID:AB_2232655); rabbit polyclonal anti-EAAT1 (GLAST) (1:5000; Abcam 231 
Cat# ab416 RRID:AB_304334); rabbit polyclonal anti-EAAT2 (GLT-1) (1:5000; Abcam 232 
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Cat# ab41621 RRID:AB_941782); rabbit polyclonal anti-Glutaminase (1:1000; Abcam Cat# 233 
ab93434 RRID:AB_10561964); rabbit monoclonal anti-Glutamine Synthetase (1:1000; 234 
Abcam: AB176562); rabbit monoclonal anti-Glucose Transporter GLUT3 (1:5000; Abcam: 235 
AB191071), rabbit monoclonal anti-Glucose Transporter GLUT1 (1:50.000; Abcam Cat# 236 
ab115730 RRID:AB_10903230); rabbit polyclonal anti-MCT1 (1:500; Santa Cruz 237 
Biotechnology Cat# sc-50325 RRID:AB_2083632); goat polyclonal anti-MCT2 (1:500; Santa 238 
Cruz Biotechnology Cat# sc-14926 RRID:AB_2187245); rabbit polyclonal anti-MCT4 239 
(1:500; Santa Cruz Biotechnology Cat# sc-50329 RRID:AB_2189333). 240 
Quantitative Real Time PCR analysis (qRT-PCR)  241 
The hippocampus was rapidly dissected on ice and frozen on dry ice and stored at -80C until 242 
used. Total RNA was isolated using Isol-RNA lysis reagent (5 PRIME, Inc. Galthersburg, 243 
USA) according to the manufacturer’s instructions, and quantified by spectrophotometry 244 
using a NanoDrop ND-1000 Spectrophotometer (NanoDrop Technologies, Wilmington, 245 
DE, USA). cDNA synthesis was performed first completing a DNase digestion step for 246 
removal of genomic DNA (Invitrogen, Stockholm, Sweden) (1U per 1ug of RNA), 247 
thereafter first-strand cDNA was carried out with equal amounts of total RNA (1 μg/ 20 μl 248 
reaction) using the iScript cDNA synthesis kit (BIO-RAD, Sundbyberg, Sweden) according 249 
to the manufacturer’s instructions and diluted with nuclease free water up to 100 μl after 250 
reaction and stored at -20C until used. A total volume of 2 μl (housekeeping) 3 μl (rest of the 251 
genes) or 6 μl (cytokines) was used for gene expression analyses, together with 10 μl SYBR® 252 
Select Master Mix (Applied Biosystems), 0.5 μM of each primer and nuclease free water up 253 
to a reaction volume of 20 μl. Taq-man pre-designed probes and TaqMan® Fast Advanced 254 
Master Mix were used for glucose transporters (Glut1 and Glut3) as well for the 255 
housekeeping TATA-box binding protein (Tbp) (Thermofisher Scientific) and prepared 256 
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following the manufacture instructions. Real-time PCR was carried out using the iCycler 257 
Real-Time PCR Detection System (Applied Biosystems). The sequences of the used primers 258 
are listed bellow (F, forward, R, reverse): 259 
Mct1 F_aatgctgccctgtcctccta, Mct1 R_cccagtacgtgtatttgtagtctccat;  260 
Mct2 F_cagcaacagcgtgatagagct, Mct2 R_tggttgcaggttgaatgctaa;  261 
Mct4 F_cagctttgccatgttcttca, Mct4 R_agccatgagcacctcaaact;  262 
Gfap F_ggggcaaaagcaccaaagaag, Gfap gggacaacttgtattgtgagcc;  263 
Aqp4 F_gagtcaccacggttcatgga, Aqp4 R_cgtttggaatcacagctggc;  264 
Gs F_tgaacaaaggcatcaagcaaatg, Gs R_cagtccagggtacgggtctt;  265 
Gls F_gctgtgctctattgaagtgaca, Gls R_ttgggcagaaaccaccattag; 266 
Actin F_gatgtatgaaggctttggtc, Actin R_tgtgcacttttattggtctc 267 
Slc2a1 (Glut1) Taqman probe Mm 00441480_m1; Slc2a3 (Glut3) Taqman probe Mm 268 
00441480_m1.; Tbp Taqman probe Mm00446973_m1. 269 
 The housekeeping gene E-actin or Tbp were used as endogenous control for normalization. 270 
The data analysis was based on the 2−ΔΔCt method. The normalized ΔCt for each gene was 271 
calculated by subtracting the Ct of the reference gene actin from the Ct of each target gene. 272 
Then, the double delta Ct (ΔΔCt) for each gene was calculated by deducting the average ΔCt 273 
of the target gene of the control group from the ΔCt of each target gene in the surgery 274 
group. The fold changes of the surgery group compared with the control group were 275 
calculated as 2−ΔΔ Ct. 276 
Immunohistochemistry (IHC)  277 
Mice were sacrificed and perfused with saline followed by 4% paraformaldehyde in 100 mM 278 
phosphate buffer. Their brains were removed, post-fixed in the same fixative overnight 279 
(4°C), and then immersed in 30% sucrose for 48 hours. Brains were then embedded in 280 
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optimal cutting temperature compound, immediately frozen on dry ice, and stored (–80ºC). 281 
Coronal sections (25-μM thick) were cut on a cryostat, mounted on glass slides using 282 
Vectashield antifade mounting media (Vector Labs; catalog H-1200), blocked for 1 hour 283 
with 5% BSA (Sigma-Aldrich) in PBS containing 0.1% Triton X-100 (Fisher Scientific), and 284 
incubated over night with an anti-GFAP antibody (1:500 rabbit polyclonal; Dako). 285 
Immunofluorescence was performed with Alexa Fluor Cy3–labeled anti–rabbit DAPI 286 
Vectashield solution (Vector Labs) to identify cell nuclei. Images were acquired by confocal 287 
laser-scanning microscopy (LSM 710 from Carl Zeiss, Germany). 288 
Image Analyses 289 
Images of the CA1 region of the hippocampus (left and right) stained for DAPI and GFAP 290 
were acquired with an inverted laser scanning confocal microscope (LSM 800) equipped with 291 
a 20X/0.8 air objective and ZEN2 (blue edition) software (Carl Zeiss, Germany). All images 292 
were taken using the same intensity settings and the person acquiring the images was blinded 293 
to the experimental conditions. Images were acquired using the z-stack function, sampling 5 294 
different depths 1um apart from the focal center of the tissue. Z-stacks images were post-295 
processed and analyzed with Image J software (RRID:SCR_003070). 296 
Lactate 297 
Approximately 10-25 mg of tissue was homogenized in 1 ml of a dry-ice chilled solution 298 
containing 80% methanol in H2O. The homogenates were then incubated at -20ºC over 299 
night, and they were then centrifuged at 12,000 rpm x 15 min to remove the insoluble 300 
fraction. The supernatants, containing soluble metabolites, were then lyophilized and 301 
subsequently re-suspended in 50 μl of sterile H2O.  The amount of lactate present in the 302 
supernatants was determined using the LACT reagent from Beckman-Coulter (Brea, CA, 303 
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USA), according to the manufacturer´s guidelines. The results were then normalized by the 304 
starting amount of tissue used to prepare the homogenate.  305 
Experimental design and Statistical Analysis 306 
An aseptic orthopedic surgery was performed on male C57BL6 and CX3CR1GFP/+CCR2RFP/+ 307 
mice under anesthesia and analgesia conditions. On average the total anesthesia time 308 
(including the induction time) was 22.2 ±1. min and animals recovered from it in about 2-5 309 
min. Experimental groups were randomly divided in three groups and sacrificed by cervical 310 
dislocation at three different time points: 6-24 and 72h post-surgery. The 24 and 72h group 311 
received a daily dose of analgesia to avoid the possible effect of pain on the brain. To avoid 312 
experimental variation over time, control animals from the same batch of animals were 313 
assigned to each of the groups and received a daily injection of saline (s.c). However, since 314 
no statistical difference was found in any of the performed experiments, all controls were 315 
pooled as a single group. The number of animals assigned per group was determined from 316 
previous experiences in the field and included into the results section for each experiment.  317 
Statistical analyses were performed using Prism Version 6 software (GraphPad; 318 
RRID:SCR_002798). D’agostino & Pearson omnibus normality test was used to test 319 
normality of values distribution. Significance of difference was analyzed using unpaired two-320 
tailed Student’s t test for single comparisons or ANOVA one-way test analysis followed by 321 
Fisher’s multiple comparisons test. In cases of variances that were not assumed to be equal, a 322 
Welch correction was performed. Data are presented as means ± SEM. P<0.05 was 323 
considered significant. 324 
325 
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Results 326 
1. Brain cytokine levels after peripheral surgery 327 
It has been previously reported that tibia fracture increases both the systemic and 328 
hippocampal expression levels of the pro-inflammatory cytokines, IL-1E and IL-6 at 6h 329 
post-surgery (Cibelli et al., 2010; Terrando et al., 2010; Fidalgo et al., 2011; Lu et al., 2015). 330 
To further explore the presence of these and other inflammatory cytokines in the brain after 331 
tibia fracture, we determined the protein levels of several hippocampal pro- and anti-332 
inflammatory cytokine by multiplex analysis (Figure 1). From all the cytokines tested (IFN-333 
gamma, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12 p70, KC/GRO/CXCL1, and TNF-Ș) 334 
we found an increase in IL-6 at 6h after tibia fracture, returning to control values at 72h 335 
post-surgery (Figure 1B; ***p=0.0002 C vs. S6H; #p=0.01 S6H vs. S72H; one-way 336 
ANOVA, Fisher’s multiple comparisons test; n=5-10 animals/group). Notably, in 337 
opposition to those studies that found increased IL-1β at 6 post-surgery (Cibelli et al., 2010; 338 
Fidalgo et al., 2011) we did find reduced IL-1β at 6 post-surgery reversed by 72h (Figure 1B; 339 
*p=0.03 C vs. S6H; ##p=0.0095 S6H vs. S72H; one-way ANOVA, Fisher’s multiple 340 
comparisons test; n=4-10 animals/group). Similarly, Rosczyk at al., (2008), comparing adults 341 
against aged animals, observed that while aged mice showed an increase IL-1β mRNA in the 342 
hippocampus after surgical trauma, adult mice showed control values of IL-1β mRNA 343 
implying that aging might be a critical factor regarding to the presence of IL-1β after 344 
peripheral surgery. 345 
2. Peripheral surgery regulates expression of astrocytic markers 346 
Cytokines, including IL-6, can cross the BBB via saturable transport (Banks et al., 1994; 347 
Gutierrez et al., 1994; Banks et al., 1995; Banks, 2005) to act directly on astrocytes, microglia 348 
and neurons. Previously, we have shown that 24h after tibia fracture, hippocampal GFAP+ 349 
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astrocytes from the stratum radiatum (SR) are morphologically altered, with astrocytes 350 
presenting shorter processes and reduced GFAP coverage. These changes were completely 351 
reversed at 72h post-surgery (Terrando et al., 2013). Hence, we sought to explore the effect 352 
of tibia fracture on the expression of two main astrocytic markers, GFAP and AQP4. Time-353 
course studies were performed in hippocampal homogenates from control and surgery-354 
treated animals between 6-, 24- and 72h following tibia fracture (Figure 2). Compared to 355 
naïve animals, the mRNA expression of both gfap and aqp4 was decreased at 24- and 72h 356 
post-surgery (Figure 2; gfap: *p=0.02 at 24H and *p=0.04 at 72H; n=5-16 animals; aqp4: 357 
*p=0.04 at 24H and *p=0.01 at 72H; n=4-12; one-way ANOVA, Fisher’s multiple 358 
comparisons test).  359 
3. Resting Ca2+ signaling is decreased in the hippocampal astrocytic network after 360 
surgery 361 
In order to evaluate the functional consequences of peripheral surgery on astrocytes we 362 
monitored spontaneous intracellular Ca2+ transients in a population of cells loaded with 363 
both, the calcium indicator OGB-1 and the astrocytic marker SR101 at 24h after tibia 364 
fracture (Figure 3A). This technique allowed us to selectively identify astrocytes among other 365 
brain cells (neurons and microglia) since in the hippocampus SR101 is taken up mainly by 366 
GFAP+ astrocytes (Kafitz et al., 2008). Nevertheless, in recent years some authors suggest 367 
that oligodendrocyte labeling may occur through transfer from astrocytes via gap-junction 368 
coupling between these two cell populations (Hill and Grutzendler, 2014).  369 
We analyzed the spontaneous Ca2+ activity in 19 and 14 hippocampal slices, from 5 control 370 
and 4 surgery-treated animals. We first observed that the number of labeled astrocytes 371 
(SR101+ cells) was significantly reduced in slices from 24h surgery-treated animals compared 372 
to hippocampal slices from control animals (Figure 3D; 35 r 2.6 vs. 49 r 3; **p=0.002; 373 
  18 
unpaired t-test; n=19-14 slices). This difference in number might be due to the reduced 374 
astrocytic GFAP coverage previously described in these animals (Terrando et al., 2013), 375 
which could make the detection of staining more difficult. However, to rule out this 376 
possibility, we analyzed the number of GFAP+ cells by immunohistochemistry and found no 377 
differences compared to control (Figure 3E; p=0.29; t-test; n=8-10 animals, unpaired t-test). 378 
Notably, we found a profound decrease in GFAP immunoreactivity (Figure 3F-G; 379 
p=0.0019; t-test; n=6-9 animals, unpaired t-test), which correlate with the decrease in gfap 380 
expression already described (Figure 2A).  381 
Next, we analyzed the percentage of active astrocytes per slice. Although the mean of the 382 
percentage of active cells did not reach significance (Figure 3H; 5.3 r 0.8 % vs. 9.9 r 2.6 %; 383 
p=0.08, unpaired t-test with Welch’s correction; n=19-14 slices (7 animals/group)), the 384 
comparison of the variance was highly significant (###p=0.0001, F test to compare 385 
variances; F: 10.36; DFn: 18; Dfd: 13) indicating different subpopulation of astrocytes 386 
among groups. Then, we analyzed the frequency of the Ca2+ events detected during a 5-387 
minute recording sequence, and found that the Ca2+ event frequency was higher in the 388 
control group (Figure 3I; 1.5 r 0.1 vs. 1.1 r 0.07 events per 5 min; *p=0.01; unpaired t-test 389 
with Welch´s correction; n=19-14 slices (4-5 animals/group)). We also recorded the Ca2+ 390 
response to ATP (100mM) during 5 min of bath application (Figure 3J). While the 391 
percentage of ATP responders was similar (not shown; 26.3 r 6.1 % vs. 22.4 r 4.1 %, C vs. 392 
S24H; n=10-15 slices; p=0.64, unpaired t-test) the frequency was significantly higher in the 393 
control group (Figure 3J; 2.1 r 0.1 vs. 1.7 r 0.1 events per 5min; *p=0.05; unpaired t-test 394 
with Welch´s correction; n=10-15 slices (7 animals/group)). Moreover, while astrocytes 395 
from hippocampal slices of naïve animals showed a heterogeneous functional profile with 396 
astrocytes able to fire 1 to 9 spikes/5min, Ca2+ signals from hippocampal slices of surgery-397 
  19 
treated animals did always show a single population of astrocytes firing 1 to 2 single Ca2+ 398 
spikes/5 min. Taken together these data suggest that peripheral surgery primarily changes 399 
the activity pattern among the most active subpopulation of hippocampal astrocytes.  400 
4. Deficiency of glucose and lactate transporters is accompanied with changes in 401 
hippocampal lactate levels after peripheral surgery 402 
A classical role attributed to astrocytes is to ensure an adequate metabolic supply to neurons. 403 
Astrocytes take up blood glucose through glucose transporters expressed in their end-feet 404 
and metabolize it to lactate, which is then delivered to neurons via lactate transporters to be 405 
used as an energy substrate in addition to glucose during high energy demands (Allaman et 406 
al., 2011) (see Figure 4A). Alterations in the regulation of this metabolic supply to neurons 407 
have been shown to have detrimental consequences in higher brain functions, such as 408 
cognition (Suzuki et al., 2011).  409 
First, we analyzed the time course for the hippocampal lactate levels between 6-, 24- and 72h 410 
following tibia fracture. Compared to controls, lactate concentration was decreased at 6- and 411 
72h after trauma, with normal levels at 24h (Figure 4B; *p=0.01 C vs. S6H; *p=0.047 C vs. 412 
S72H; p=0.7 C vs. S24H; n=5 animals/group; one-way ANOVA, Fisher’s multiple 413 
comparisons test).  414 
Second, we evaluated the expression pattern of the two main glucose transporters in the 415 
brain: GLUT-1 (expressed in the astrocytic end-feet) and GLUT-3 (expressed in neurons). 416 
Both, glut-1 and glut-3 gene expression was down-regulated at 6h after trauma (Figure 4C 417 
(top); glut-1: **p=0.0031, S6H vs. C; n=5-15; glut-3: ***p<0.0002 S6H vs. C; n= 5-15 418 
animals, respectively; one-way ANOVA, Fisher’s multiple comparisons test). Protein levels 419 
were decreased at 72h after surgery for GLUT-1 (Figure 4B (bottom)-C; *p=0.019, S72H vs. 420 
C; n=5 animals/group; one-way ANOVA, Fisher’s multiple comparisons test) and decreased 421 
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at 24h and 72h for GLUT-3 (Figure 4C (bottom); **p=0.001, S24H vs. C; n=5/group; 422 
**p=0.002, S72H vs. C; n=5-5 animals; one-way ANOVA, Fisher’s multiple comparisons 423 
test). 424 
Finally, we analyzed the main brain lactate transporters, monocarboxylate transporters 425 
(MCTs) 1, 2 and 4, being MCT1 and MCT4 expressed in astrocytes and MCT-2 in neurons. 426 
Mct1 was significantly decreased at 6h, normal at 24h and decrease at 72h (Figure 4D (top); 427 
*p=0.05 S6H vs. C; n=6-15 animals; *p=0.032, S72Hvs. C; n=5-15 animals; one-way 428 
ANOVA, Fisher’s multiple comparisons test); mct2 was significantly decreased at 72h 429 
(Figure 4D (top); *p=0.042, S72H vs. C; n=5-15 animals; one-way ANOVA, Fisher’s 430 
multiple comparisons test), and mct4 dramatically increased at 24h (Figure 4D; 431 
****p<0.0001, S24H vs. C; n=5-14 animals; one-way ANOVA, Fisher’s multiple 432 
comparisons test). Western blot analysis of hippocampal homogenates did not revealed any 433 
alteration in any of the brain lactate transporters tested (Figure 4D (bottom) and E).  434 
5. Peripheral surgery affects hippocampal proteins involved in glutamate metabolism 435 
In addition to their role in neuronal energy supply, astrocytes are also vital cell elements in 436 
the reuptake and recycling of glutamate in the synapse. Through glutamate transporters 437 
(GLAST and GLT-1), astrocytes regulate glutamate release in the synapse by converting 438 
glutamate to glutamine through the glutamine synthase (GS) pathway, before releasing it to 439 
the extracellular space via glutaminases (GLS1). The released glutamine is subsequently taken 440 
up by neurons and re-used as substrate for glutamate production to replenish the presynaptic 441 
neurotransmitter pool and help to maintain synaptic transmission (see Figure 5A).  442 
We analyzed the mRNA and protein levels of the enzymes involved in the glutamate-443 
glutamine cycling, such as GLAST, GLT-1, GS and GLS1 at several time points after 444 
peripheral surgery.  445 
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By qRT-PCR we found a profound increase in the mRNA levels of the enzyme gs at 6- and 446 
24h (Figure 5B; **p=0.001; S6H vs. C; n=6-15 animals; **p=0.005; S24H vs. C; n=5-15 447 
animals; one-way ANOVA, Fisher’s multiple comparisons test) followed by a drastic 448 
reduction at 72h post-surgery (*p=0.04, S72H vs. C; n=5-15 animals; one-way ANOVA, 449 
Fisher’s multiple comparisons test. Similarly, we found a reduction in protein at 72h post-450 
surgery (Figure 5C and D, *p=0.019, S72H vs. C; n=5 animals/group). Gene expression of 451 
gls1 showed a decrease at 24- and 72h after surgery (Figure 5B; *p=0.01, S24H vs. C; 452 
*p=0.02, S72H vs. C; 5-15 animals; one-way ANOVA, Fisher’s multiple comparisons test), 453 
although no changes at the protein level were detected (Figure 5C and D). 454 
6. Functional and structural neuronal synaptic changes occur in the hippocampus at 455 
72h post-surgery  456 
To further explore how tibia fracture affects the glutamatergic system we analyzed the 457 
proteins levels of the two most common subunits of the AMPA-Rs (GluA1 and GluA2) by 458 
western blot. At 72h, we found a profound increase in the GluA1 compared to controls 459 
(Figure 6A (left) and C; **p=0.004; C vs. 72H; n=5-6 animals; one-way ANOVA, Fisher’s 460 
multiple comparisons test) and a reduction in the GluA2 subunit (Figure 6A (right) and C; 461 
*p=0.01; C vs. S72H; n=5-6 animals; one-way ANOVA, Fisher’s multiple comparisons test). 462 
In addition, we analyzed the glial glutamate transporters, GLAST and GLT-1, at the same 463 
time points (24h and 72h-post-surgery). At 72h, we found a reduction in the protein GLAST 464 
(Figure 6B (left) and C; **p=0.0017; C vs. 72H; n=5-6 animals; one-way ANOVA, Fisher’s 465 
multiple comparisons test) but no changes in GLT-1 (Figure 6B (right) and C; p=0.9; n=5-6 466 
animals one-way ANOVA, Fisher’s multiple comparisons test). 467 
In addition to its role in glutamate recycling, GLAST plays an essential role in terminating 468 
synaptic transmission and maintaining safety levels of extracellular glutamate, since excessive 469 
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amounts of glutamate would cause excitotoxicity via glutamate receptors (Figure 6D). 470 
Similarly, alterations in AMPA-Rs subunit composition and reduced GLAST have been 471 
associated with increased glutamatergic transmission (Gómez-Galán et al., 2016; 2013). We 472 
finally investigated neuronal synaptic transmission after peripheral trauma by whole-cell 473 
patch clamp recordings from CA1 pyramidal cells measuring spontaneous excitatory 474 
postsynaptic currents (sEPSCs) at 24h and 72h post-surgery. While at 24h, the frequency 475 
(Figure 6E (top); Hz: 1.5 r 0.2 vs. 2r 0.3; C vs. S24H; unpaired t-test; t=1.025, df=24; 476 
p=0.3; n=8-18 cells (4-6 animals/group)) and the amplitude (Figure 6E (bottom) pA: 18.5 r 477 
0.6 vs. 18.5 r 0.6; C vs. S24H; unpaired t-test; t=0,0013, df=24; p=0.99; n=8-18 cells (4-6 478 
animals/group)) of the sEPSCs events were similar to control animals, at 72h we detected an 479 
increase in both the frequency (Figure 6F (top); Hz: 3.2 r 0.3 vs. 5.5 r 0.6; C vs. S72H; 480 
unpaired t-test; t=3.319, df=35.22; **p=0.002; n=22-26 cells (7 animals/group) and 481 
amplitude (Figure 6F (bottom); pA: 17.9 r 0.7 vs. 21 r 0.8; C vs. S72H; unpaired t-test; 482 
t=2.848, df=46; **p=0.007; n=22-26 cells (7 animals/group)) of sEPSCs compared to 483 
control, reflecting an increase in glutamatergic transmission. This increase in excitability may 484 
suggest an imbalance between the glutamatergic and the GABAergic (inhibitory) system. To 485 
rule out this hypothesis we analyzed spontaneous inhibitory postsynaptic currents (sIPSCs) 486 
from CA1 pyramidal cells at 72h. We did not find any difference between control and 487 
surgery-treated animals (Figure 6G; Freq: p=0.79; Ampl: p=0.27; t-test; n=9-13 cells (3 488 
animals/group)).  489 
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Discussion 490 
The overarching aim of the present study was to determine the underlying temporal 491 
alterations associated with systemic immune activation after peripheral surgery on brain 492 
neuronal-glial function within hippocampal neuronal circuits of relevance for cognitive 493 
processing. Here, we uncover a series of astrocyte and neuronal metabolic, structural and 494 
physiological changes in the hippocampus, which reinforce the idea of a dynamic peripheral-495 
to-brain communication and emphasize the role of astrocytes as key intermediaries between 496 
peripheral immune events and neuronal processing of information and cognition. 497 
Previous studies have identified a transient disruption of the BBB mediated by the pro-498 
inflammatory milieu after surgery. Through a permeable BBB, cytokines and inflammatory 499 
mediators, such as macrophages, were shown to migrate into the hippocampus and 500 
modulate its function contributing to postoperative cognitive decline (Terrando et al., 2011; 501 
Degos et al., 2013; Yang et al., 2017). These studies also found increased hippocampal 502 
mRNA expression of IL-1β and IL-6 at 6h post-surgery, which is in line with the presence 503 
of the pro-inflammatory cytokine IL-6 protein in the hippocampus, suggesting that 504 
hippocampal inflammation may contribute to the mechanisms responsible for postoperative 505 
cognitive changes. Similarly, clinical studies have reported an increase in cytokines levels, 506 
including IL-6, in the cerebrospinal fluid of patients after non-neurological surgery 507 
(Buvanendran et al., 2006; Bromander et al., 2012; Hirsch et al., 2016). 508 
Astrocytes are critical components of the neurovascular unit, which is a key interface 509 
between the periphery and CNS (Kisler et al., 2017). They express cell surface receptors for 510 
most cytokines, including IL-1β and IL-6 (Lovatt et al., 2007; Cahoy et al., 2008) and several 511 
studies have shown that astrocytes respond to cytokines and inflammatory mediators by 512 
altering their morphology and transcriptome profiles, including those related with structural 513 
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proteins and Ca2+ signaling (Hamby et al., 2012; Zamanian et al., 2012; Sofroniew, 2014). 514 
Here we detected a decrease gene expression of the astrocyte markers GFAP and AQP4 515 
accompanied with profound decrease in GFAP immunoreactivity and alterations in the 516 
resting Ca2+ signaling at 24h post-surgery. GFAP is an intermediate filament protein 517 
involved in the structure and function of the astrocyte’s cytoskeleton whose expression is 518 
known to be essential for BBB integrity (Liedtke et al., 1996). Similarly, AQP4 is typically co-519 
expressed with GFAP in astrocytes where it is highly polarized to astrocytic end-feet in close 520 
contact with blood vessels (Verkman et al., 2006) and participates in BBB formation 521 
(Nicchia et al., 2004; Blixt et al., 2015). Although the mechanisms related to BBB integrity 522 
after peripheral trauma was not the focus of the study, these new findings together with our 523 
previous observation of reduced hippocampal GFAP coverage in astrocytes (Terrando et al., 524 
2013) support previous observation of surgery-induced BBB disruption at 24h post-trauma 525 
(Terrando et al., 2011). 526 
The reduction in GFAP and AQP4 expression and GFAP coverage observed after surgery 527 
may significantly affect astrocytes function, therefore disrupting neuronal circuits involved in 528 
higher brain functions, including cognition. Spontaneous or ligand-evoked changes in 529 
intracellular Ca2+ concentration represent a form of astrocyte excitability that can enable 530 
astrocytes to modulate neuronal activity and behavior (Perea et al., 2009; Halassa and 531 
Haydon, 2010; Henneberger and Rusakov, 2010). Here, we found reduced astrocytic resting 532 
Ca2+ signaling evidenced by a reduction in the percentage of active cells within slices and 533 
lower Ca2+ signal frequency at 24h post-trauma. Opposite to our findings, Ca2+ imaging 534 
studies from animal models of some brain pathologies, including stroke (Takatsuru et al., 535 
2013), epilepsy (Ding et al., 2007) and AD (Abramov et al., 2003; Kuchibhotla et al., 2009) 536 
have shown enhanced astrocytic Ca2+ excitability. Although the mechanisms underlying this 537 
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increase may differ among these pathologies, a common feature between them, and a 538 
difference with our model, is the presence of reactive astrocytes, including up-regulation of 539 
GFAP and hypertrophy (Fedele et al., 2005; Osborn et al., 2016; Sims and Yew, 2017). We 540 
believe it is possible that some of the aspects related to the mechanisms involved in Ca2+ 541 
regulation in astrocytes may depend on the origin of the insult or even on the stage of the 542 
disorder. 543 
Interesting, studies performed in the hippocampus of a triple transgenic mouse model of 544 
AD showed early (at 6 month age) reduction in GFAP surface and volume accompanied by 545 
a reduction of the glial branching, which progressed with age. Conversely, astrocytes 546 
surrounding amyloid plaques presented the typical reactive characteristics with thick 547 
processes and enlarged cell bodies (Olabarria et al., 2010). It would be interesting to apply 548 
this model to investigate if such morphological changes also correlate with opposing changes 549 
in Ca2+ signaling. Notably, functional studies in these animals have shown synaptic plasticity 550 
and long-term memory deficits preceding the appearance of amyloid plaques and tangles 551 
(Oddo et al., 2003a; Oddo et al., 2003b). 552 
Alterations in intracellular Ca2+ signaling after surgery may affect the release of 553 
gliotransmitters from astrocytes, including glutamate, ATP, D-serine and GABA with the 554 
potential to generate a wide range of functional alterations related to synaptic transmission 555 
and plasticity (Parpura et al., 1994; Zonta et al., 2003). In addition, Ca2+ evoked release of 556 
messengers from astrocytes has also been suggested to regulated the energy supply to the 557 
brain (Wang et al., 2009; Bazargani and Attwell, 2016). Here, together with the functional 558 
changes observed in astrocytes, we found distinct temporal hippocampal alterations in 559 
glucose and glutamate signaling accompanied with changes in whole lactate levels at several 560 
time points after peripheral trauma suggesting a neuro-glial metabolic uncoupling in the 561 
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hippocampus. Lactate is produced by astrocytes via non-oxidative glucose utilization and 562 
shuttled to neurons via MCTs where it is used as an energy substrate (Allaman et al., 2011). 563 
The early decrease in the gene expression of the two main glucose transporters in the brain 564 
(GLUT 1-astrocyte- and GLUT 3-neuron-) accompanied with a reduction in hippocampal 565 
lactate levels points to an early alteration in the mechanisms responsible for the uptake of 566 
glucose by both, astrocytes and neurons. Interestingly, at 24h post-surgery and coinciding 567 
with normal lactate levels, the MCT4, a transporter exclusively located in astrocytes and 568 
highly involved in lactate efflux to neurons (Pierre and Pellerin, 2005), shows a transient but 569 
profound up-regulation. Supported by the astrocyte-neuron lactate shuttle (ANLS) 570 
hypothesis proposed by Pellerini and Magistretti (Pellerin and Magistretti, 1994); but see also 571 
(Magistretti, 2009; Barros and Deitmer, 2010), in which lactate release and concomitant 572 
glucose uptake in astrocytes is stimulated by sodium-coupled uptake of glutamate from 573 
glutamate transporters, we suggest that in our model this temporal up-regulation in astrocytic 574 
lactate signaling at 24h post-surgery followed by a decline in lactate levels at 72h may 575 
indicate a failed protective attempt from astrocytes to provide with the energy requirements 576 
necessary to maintain neuronal activity and the associated brain functions, such as cognition.  577 
The functional significance of lactate for cognition after surgery is further supported by 578 
other findings showing that interference with lactate transport from astrocytes into neurons 579 
impairs synaptic plasticity and memory (Newman et al., 2011; Suzuki et al., 2011). 580 
Indeed, parallel to the synaptic plasticity and cognitive dysfunction previously reported 581 
(Terrando et al., 2013), at 72h post-surgery we observed the main protein machinery 582 
involved in the control of glutamate neurotransmission and energy metabolism (performed 583 
by astrocytes) down-regulated, including the glial glutamate (GLAST) and glucose (GLUT-1) 584 
transporters, but also the enzymes involved in the glutamate-glutamine cycle, such as GS and 585 
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GLS1. In addition, the increased neuronal glutamatergic transmission here described at 72h 586 
post-surgery in form of increase sEPSCs frequency and amplitude may be the functional 587 
consequence of the above mentioned alterations in the reuptake and recycling of glutamate 588 
by the astrocyte further accompanied by neuronal alterations in AMPA receptor subunit 589 
composition (GluA1 vs. GluA2). Association between decreased GLAST protein levels and 590 
increased sEPSCs and impaired synaptic plasticity have also been reported in a rat model of 591 
depression characterized with astrocytic morphology alterations and cognitive deficits 592 
(Gómez-Galán et al., 2013). Notably, 5 weeks of social isolation in these rats also down-593 
regulated the protein levels of the GluA2 subunit of AMPA receptors (Gómez-Galán et al., 594 
2016). In the hippocampus, the ability of Ca2+ to enter the neuronal cell through the AMPA 595 
receptor is determined by the GluA1 subunit, which is highly permeable to Ca2+ (Cull-Candy 596 
et al., 2006). Indeed, it has been shown that activation of GluA2-lacking receptors induces a 597 
retrograde signal that enhances release probability at the presynaptic terminal (Lindskog et 598 
al., 2010). Other studies have shown increased excitability and impaired synaptic plasticity 599 
and memory associated with changes in Ca2+-permeable AMPA receptors (Cull-Candy et al., 600 
2006). Thus, in this surgical model a reduction of GluA2 may increase the probability of 601 
glutamate release that together with the reduction in glutamate uptake by the astrocyte, will 602 
contribute to increased levels of extracellular glutamate and to a concomitant increase in 603 
glutamate transmission. Since astrocytes do also express AMPA receptors further studies are 604 
necessary to address if peripheral surgery affect differently glial and neuronal AMPA-R 605 
subunit composition and function. 606 
In summary, we demonstrate that peripheral surgery following systemic immune activation 607 
orchestrates temporal metabolic adaptations in the hippocampus, including alteration in 608 
glucose and glutamate signaling in astrocytes, and reduction in brain lactate availability. As a 609 
  28 
consequence, the neuro-glial metabolic coupling is compromised as well as the astrocyte and 610 
neuronal function suggesting that the decrease in lactate availability in the hippocampus after 611 
peripheral trauma might be related to the cognitive impairment observed acutely after 612 
trauma.   613 
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Figure legends 810 
 811 
Figure 1. Brain cytokine levels after peripheral surgery 812 
Hippocampal cytokine expression was assessed at 6- and 72h post-surgery using a multiplex 813 
assay for 10 different cytokines. While the pro-inflammatory cytokine IL-6 is increased at 6h 814 
after surgery (IL6: ***p=0.0002 C vs. S6H, #p=0.01 S6H vs. S72H, One-way ANOVA, 815 
Fisher’s multiple comparison test) IL-E is decreased (*p=0.03 C vs. S6H; ##p=0.0095 S6H 816 
vs. S72H). Empty dots on each graph represent individuals. Initially, numbers of animals 817 
were similar for each cytokine (C: n=10; S6H: n=5; S72H: n=5). However, those values 818 
which lay bellow the detectable range were excluded from the analysis. N.D: non-detectable. 819 
All data are presented as the mean ± SEM. 820 
 821 
Figure 2. Peripheral surgery regulates expression of astrocytic markers  822 
Analysis of gene expression by qRT PCR of glial cells markers at 6-24- and 72h post-surgery. 823 
The astrocytic markers A. glial fibrillary acidic protein (GFAP) and B. Aquaporin 4 (AQP4) 824 
are down-regulated at 24- and 72h post-surgery. (gfap: *p=0.02 C vs. S24H and *p=0.04 C 825 
vs. S72H; n=5-16 animals; Aqp4: *p=0.04 at C vs. S24H and *p=0.01 C vs. S72h; n=4-12 826 
One-way ANOVA, Fisher’s multiple comparison test). All data are presented as the mean ± 827 
SEM. 828 
 829 
Figure 3. Resting calcium signaling is decreased in the hippocampal astrocytic 830 
network after surgery 831 
A. Representative hippocampal slice from a control animal loaded with the astrocytic marker 832 
S101 (red) and the calcium dye OGB-1M (green) and the corresponding overlay (yellow). B. 833 
A frame of a time-lapse imaging from the same slice in A with the active cells highlighted by 834 
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a yellow circle. C. Traces of calcium spontaneous activity of the astrocytes outlined in C 835 
(from a control animal; left) and from a surgery-treated animal 24h-post surgery (S24H; 836 
right). D. 24h after surgery there is a decrease in the number of S101+ cells (**p=0.002; 837 
unpaired t-test; n=19-14 slices). E-F-G. Hippocampal GFAP immunohistochemistry shows 838 
similar number of GFAP+ cells between control and surgery-treated animals (n=8-10 839 
animals) (E) but profound decrease in GFAP immunoreactivity after surgery (F-G; 840 
**p=0.0019; unpaired t-test; n=6-9 animals). H. The distribution of the percentage of active 841 
astrocytes is reduced after surgery (###p=0.0001, unpaired t-test Welch’s correction; F test 842 
to compare variances; F: 10.36; DFn: 18; Dfd: 13; n=14-19 slices). I. At 24h-post surgery the 843 
frequency of the spontaneous (*p=0.01; unpaired t-test with Welch´s correction; n=19-14 844 
slices (4-5 animals/group)) and J. ATP-evoked calcium spikes is decreased (*p=0.05; 845 
unpaired t-test with Welch´s correction; n=10-15 slices (7 animals/group). All data are 846 
presented as the mean ± SEM. 847 
 848 
Figure 4. Glucose and lactate transporters deficiency is accompanied with changes in 849 
hippocampal lactate levels after peripheral surgery 850 
A. Schematic diagram of the astrocyte–neuron lactate shuttle. B. Lactate levels in the whole 851 
hippocampal homogenates are decreased at 6- and 72h post-surgery (*p=0.01, C vs. S6H 852 
and *p=0.047, C vs. S72H; One-way ANOVA, Fisher’s multiple comparison test; n= 5 853 
mice/ group). C. Astrocyte glucose transporter GLUT1 and neuronal GLUT3 mRNA 854 
expression is decreased at 6h-post-surgery (Glut-1: **p=0.031; glut-3: ***p<0.0022; One-855 
way ANOVA, Fisher’s multiple comparison test; n= 5-15 mice/group). Protein levels were 856 
decreased at 72h after surgery for GLUT-1 *p=0.019, S72H vs. C; n=5 mice/group) and 857 
decreased at 24h and 72h for GLUT-3 **p=0.001, S24H vs. C; **p=0.002, S72H vs. C; n= 5 858 
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mice/group). D. Monocarboxilate transporters mRNA expression is also affected after 859 
surgery (Mct1: *p=0.05 C vs. S6H, *P=0.032 C vs. S72H; mct2: p=0.054 C vs. 6H; 860 
*p=0.042 C vs. S72H; mct4: ****p<0.0001 C vs. S72H; One-way ANOVA, Fisher’s multiple 861 
comparison test; n=5-15 mice/group). E. Corresponding protein blots for each protein 862 
(normalized to Ponceau S). Triplicates in each group represent different animals. All data are 863 
presented as the mean ± SEM. 864 
 865 
Figure 5. Peripheral surgery affects hippocampal enzymes involved in glutamate 866 
metabolism 867 
A. Schematic illustration outlining the glutamate-glutamine cycle between astrocyte and 868 
neurons. B. Astrocyte glutamine synthase (GS) and Neuronal Glutaminase-1 (GLS1) mRNA 869 
expression and C. protein levels (*p<0.05, **p<0.01 vs. C, One-way ANOVA, Fisher’s 870 
multiple comparison test; mRNA: n= 5-15 mice/group; protein: n= 5 mice/group). D. 871 
Panels represent the corresponding protein blots for each protein (normalized to Ponceau 872 
S). Triplicates in each group represent different animals. All data are presented as the mean 873 
± SEM. 874 
 875 
Figure 6. Functional and structural neuronal synaptic changes occur in the 876 
hippocampus at 72h post-surgery 877 
A. AMPA receptor subunits GluA1 and GluA2 are affected at 72h post-surgery (left, 878 
GLUA1: **p=0.0017 C vs. S72H; right, GLUA2: *p=0.01 C vs. S72H; One-way ANOVA, 879 
Fisher’s multiple comparison test; n= 3-6 animals/group). B. GLAST is down-regulated at 880 
72h post-surgery (left, GLAST: **p=0.0017 c vs. S72H, One-way ANOVA, Fisher’s 881 
multiple comparison test; n= 3-6 animals/group) but not effect is observed in GLT-1 882 
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(right).  C. Representative blots of individual hippocampal samples from control, 24- and 883 
72h surgery-treated mice of the two most common subunits of the AMPARs (GLUR1 and 884 
GLUR2) and the astrocytic glutamate transporters (GLAST and GLT-1) (normalized to the 885 
transfer Ponceau S). D. Schematic illustration outlining the neuronal glutamate synapse (left) 886 
and the representative examples of whole-cell patch clamp recordings from a CA1 pyramidal 887 
cell from control (top-right) and surgery-treated mouse 72h post-surgery (bottom-right). E. 888 
At 24h the frequency (top) and amplitude (bottom) remains normal (n= 8-18 cells; 4-6 889 
animals/group).  F. At 72h post-surgery the frequency (top) and amplitude (bottom) of 890 
sEPSCs is increased in the CA1 area of surgery-treated mice (**p=0.002, t-test; n=22-26 891 
cells; 7-11 animals/group). G. The inhibitory (GABA) system remains unaffected at 72h 892 
post-surgery (n= 9-13 cells; 3 animals/group). All data are presented as the mean ± SEM. 893 
 894 
Figure 7. Schematic illustration summarizing the effect of orthopedic mice surgery 895 
on hippocampal astrocyte-neuron metabolism, structure and function 896 
Orthopedic surgery in mice (i.e. tibia fracture) temporally orchestrates a series of 897 
hippocampal metabolic, structural and functional changes first in the astrocyte and later in 898 
neurons that emphasize the role of astrocytes as key intermediaries between peripheral 899 
immune events and neuronal processing information and potentially to cognition. Red 900 
arrows depict decreased mRNA/protein levels.  901 
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Orthopedic surgery in mice asssociates with temporal
structural and functional changes in hippocampal astrocytes leading to a disruption of the 
neuro-glial metabolic coupling and consequently to neuronal dysfunction
